The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults
NCT ID: NCT07209683
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
30 participants
INTERVENTIONAL
2025-09-29
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Does tPBM enhance neurovascular coupling responses during memory and finger tapping tasks?
* Are these improvements linked to better cognitive performance and lower levels of brain inflammation and oxidative stress?
Researchers will compare an active tPBM treatment arm to a sham treatment arm to see if tPBM leads to measurable improvements in brain activity and cognitive function compared to no active stimulation.
Participants will:
* Receive either active tPBM or sham stimulation sessions for 4 weeks, every other day using a portable intervention device.
* Complete questionnaires and an iPAD-based cognitive testing protocol
* Complete memory and motor tasks while their brain activity is measured using non-invasive techniques: simultaneous functional near-infrared spectroscopy (fNIRS) and electroencephalography (EEG), transcranial doppler (TCD) flowmetry.
* Retinal vessel reactivity will be measured during flickering light stimulus using a special camera (dynamic vessel analysis, DVA).
* Provide blood samples to test for biomarkers of inflammation, oxidative stress and brain cell damage.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
tPBM in Older Adults With Traumatic Brain Injury
NCT06956404
Effect of Transcranial NIR Light Upon Memory
NCT04568057
Transcranial Photobiomodulation Intervention for Healthy Older Adults
NCT04608370
Brain Vascular and Neurocognitive Health
NCT06497413
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
NCT05802680
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Transcranial photobiomodulation (tPBM) has emerged as a promising, non-invasive technique with the potential to enhance both neuronal and vascular health. tPBM delivers near-infrared light to cortical areas, stimulating mitochondrial activity, reducing oxidative stress, and improving cerebral hemodynamics. There is increasing evidence that tPBM, which uses red and infrared light with specific wavelengths, confers benefit in various neurological, cardiovascular, and cerebrovascular disorders. However, the underlying neurophysiological changes need to be clarified in human studies, and there are further patient populations who would benefit from a tPBM-based intervention. Optical imaging devices, such as near-infrared spectroscopy (NIRS), offer a means to evaluate tPBM-related changes in brain oxygenation and hemodynamics in an out-of-lab environment, which would significantly improve the feasibility of trials focusing on the effects of tPBM on cerebrovascular health. The practical advantages of tPBM lie in its documented safe application, simplicity of use, affordability, and the potential for home-based interventions.
Recent studies have demonstrated a strong association between cognitive performance and NVC responses in healthy older adults and in patients with mild cognitive impairment. Neuronal activity-induced vasodilation is largely mediated by nitric oxide (NO), whose dissociation from cytochrome c oxidase (CCO) and thus bioavailability is promoted by tPBM. It has also been shown that tPBM confers anti-inflammatory effects in the brain, which is relevant given the heightened inflammatory processes in older adult,s implicating aging-induced neuroinflammation. However, limited clinical evidence exists on the impact of tPBM on NVC, particularly in aging individuals. Moreover, existing research focuses on cognitive benefits rather than neurophysiological or hemodynamic changes, with minimal integration of these outcomes. Addressing this gap, this proposal aims to leverage advanced multimodal neuroimaging techniques to investigate the age-specific tPBM-improvements in NVC and its association with the effects on cognitive function.
Preclinical and early clinical studies suggest that tPBM enhances microvascular perfusion and tissue oxygenation, while simultaneously reducing neuroinflammation and oxidative stress. These dual effects underscore its potential as a multifaceted tool for promoting neural and vascular recovery. To date, evaluations of tPBM in various populations have shown it to be a safe intervention with transient and mild headache as the most common and considerable adverse effect induced by the sessions. Its non-pharmacological nature and compatibility with existing treatments further support its use as an innovative approach for cognitive rehabilitation.
The significance of this project lies in its potential to develop a novel, non-invasive intervention for cognitive impairment in aging populations and also in its ability to elucidate the underlying mechanisms of NVC modulation by tPBM. Findings from this research will provide critical insights into the dual neural and vascular effects of tPBM, laying the groundwork for future combination therapies to address age-related cognitive decline.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active near-infrared light therapy
Participants in this arm will receive active transcranial photobiomodulation sessions every other day for 20 minutes during their participation in the study. The intervention will be administered by active Vielight Neuro Rx Gamma, a research version of a commercially available light therapy device categorized as a wellness product with non-significant risk. During these sessions, biologically effective near-infrared light will be administered.
transcranial photobiomodulation
The Vielight Neuro Gamma TPBM devices (©Vielight Inc.) will be used to transmit pulsed near-infrared (NIR) energy through the cranium. Device emits NIR photons at 810 m wavelength generating \~100 mW/cm2 pulsed NIR power modulated at 40 Hz frequency. The six NIR light sources are positioned along the midline over the frontal, pariatel and occipital cortices, bilaterally over the temporal cortex, and intranasally. Due to its portable design, Vielight Neuro TBPM instruments can be used in the laboratory, bedside, or at the participant's home.
Active / sham photobiomodulation sessions last for 20 minutes and will be administered at a laboratory-, home-, or office-based setting depending on the preference of the participant. TPBM will be performed three or four times a week for four weeks, maximum once every other day. Participants will complete a questionnaire of adverse events after each photobiomodulation session.
Sham near-infrared light therapy
Participants in this arm will receive sham transcranial photobiomodulation sessions every other day for 20 minutes during their participation in the study. The intervention will be administered by active Vielight Neuro Rx Gamma, a research version of a commercially available light therapy device categorized as a wellness product with non-significant risk. During these sessions, biologically effective near-infrared light will not be administered.
transcranial photobiomodulation
The Vielight Neuro Gamma TPBM devices (©Vielight Inc.) will be used to transmit pulsed near-infrared (NIR) energy through the cranium. Device emits NIR photons at 810 m wavelength generating \~100 mW/cm2 pulsed NIR power modulated at 40 Hz frequency. The six NIR light sources are positioned along the midline over the frontal, pariatel and occipital cortices, bilaterally over the temporal cortex, and intranasally. Due to its portable design, Vielight Neuro TBPM instruments can be used in the laboratory, bedside, or at the participant's home.
Active / sham photobiomodulation sessions last for 20 minutes and will be administered at a laboratory-, home-, or office-based setting depending on the preference of the participant. TPBM will be performed three or four times a week for four weeks, maximum once every other day. Participants will complete a questionnaire of adverse events after each photobiomodulation session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcranial photobiomodulation
The Vielight Neuro Gamma TPBM devices (©Vielight Inc.) will be used to transmit pulsed near-infrared (NIR) energy through the cranium. Device emits NIR photons at 810 m wavelength generating \~100 mW/cm2 pulsed NIR power modulated at 40 Hz frequency. The six NIR light sources are positioned along the midline over the frontal, pariatel and occipital cortices, bilaterally over the temporal cortex, and intranasally. Due to its portable design, Vielight Neuro TBPM instruments can be used in the laboratory, bedside, or at the participant's home.
Active / sham photobiomodulation sessions last for 20 minutes and will be administered at a laboratory-, home-, or office-based setting depending on the preference of the participant. TPBM will be performed three or four times a week for four weeks, maximum once every other day. Participants will complete a questionnaire of adverse events after each photobiomodulation session.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adequate hearing and visual acuity to participate in the examinations
* Ability to read and write in English
* Competence to provide informed consent
Exclusion Criteria
* Cerebrovascular accident other than TIA within 60 days prior to Visit 0
* Major psychiatric disease, including major depression not currently controlled on medications, alcohol or drug abuse
* Participant currently uses commercial brain stimulation / neuromodulation device or an experimental device as part of a research study, e.g. tDCS, tACS, TBS, DBS, TMS, TPBM, etc.
* Participant currently takes dietary supplements with an expected cerebrovascular benefit, such as NAD- or NR-supplementum, L-citrullin, urolithin
* Unstable medical condition, including uncontrolled diabetes, chronic heart issues, heart failure, chronic obstructive pulmonary disease, Stage 2 hypertension uncontrolled by medication (\>160/100 mmHg)
* Any other medical condition or medication which, in the opinion of investigator, would render the patient inappropriate or too unstable to complete the study protocol.
* Pregnancy or trying to become pregnant in the next 1 months (self-reported), breastfeeding
21 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oklahoma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Oklahoma Health Campus
Oklahoma City, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
OUHSC Director, Office of H. R. P. P.
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Chao LL. Effects of Home Photobiomodulation Treatments on Cognitive and Behavioral Function, Cerebral Perfusion, and Resting-State Functional Connectivity in Patients with Dementia: A Pilot Trial. Photobiomodul Photomed Laser Surg. 2019 Mar;37(3):133-141. doi: 10.1089/photob.2018.4555. Epub 2019 Feb 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18356
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.